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Abstract
Background: Italy has a population of 60 million and a universal coverage single-payer healthcare system, which mandates
collection of healthcare administrative data in a uniform fashion throughout the country. On the other hand, organization of
the health system takes place at the regional level, and local initiatives generate natural experiments. This is happening in
particular in primary care, due to the need to face the growing burden of chronic diseases. Health services research can
compare and evaluate local initiatives on the basis of the common healthcare administrative data.However reliability of
such data in this context needs to be assessed, especially when comparing different regions of the country. In this paper we
investigated the validity of healthcare administrative databases to compute indicators of compliance with standards of care
for diabetes, ischaemic heart disease (IHD) and heart failure (HF).
Methods: We compared indicators estimated from healthcare administrative data collected by Local Health Authorities in
five Italian regions with corresponding estimates from clinical data collected by General Practitioners (GPs). Four indicators
of diagnostic follow-up (two for diabetes, one for IHD and one for HF) and four indicators of appropriate therapy (two each
for IHD and HF) were considered.
Results: Agreement between the two data sources was very good, except for indicators of laboratory diagnostic follow-up
in one region and for the indicator of bioimaging diagnostic follow-up in all regions, where measurement with
administrative data underestimated quality.
Conclusion: According to evidence presented in this study, estimating compliance with standards of care for diabetes,
ischaemic heart disease and heart failure from healthcare databases is likely to produce reliable results, even though
completeness of data on diagnostic procedures should be assessed first. Performing studies comparing regions using such
indicators as outcomes is a promising development with potential to improve quality governance in the Italian healthcare
system.
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Introduction
Primary care is specifically suitable to face the growing chronic
disease epidemic in a sustainable way [1,2]. Therefore it is the
object of novel attention and of innovative policies [3] which
specifically need health services research for timely effectiveness
evaluation [4–7].
Many observational studies have been performed to evaluate
the impact of innovative policies in primary care, for instance
alternative rewarding policies for General Practitioners (GPs) in
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Ontario [8] or incentives for the introduction of Electronic Health
Records in the United States [9,10]. Such studies use administra-
tive data to obtain evidence on the impact of policies in a
inexpensive, timely and reproducible fashion [11]. Indicators
measuring compliance with standards for management of chronic
diseases were used as outcomes in those studies, similar to the
clinical indicators of the Quality and Outcome Framework of the
UK National Health System [12], such as regular prescription of
recommended therapies and regular diagnostic follow-up. How-
ever, concerns have been raised that such indicators estimated on
the basis of administrative databases might not reflect the actual
compliance of standards in the population bearing the disease, as
methods to identify patients from administrative data, rather than
clinical information, might lead to biased samples. Studies
addressing this issue have obtained contradictory findings [13,14].
As a result of those concerns, comparison of quality of primary
care between regions or countries is generally performed by means
of hospitalization rates for the so-called ambulatory care sensitive
conditions [15], which are readily obtained from administrative
databases but do not require identification of cohorts of patients
with a specific condition. However the relationships between
quality of primary care and avoidable hospitalization is complex
and population-based trends can be confounded by socioeconomic
factors [16], by prevalence of morbidity or general hospitalization
habits [17].
In Italy, the VALORE Project was the first national-level study
which evaluated a national policy in primary care by using
administrative healthcare data for calculation of indicators of
compliance [18]. This paper presents the validation study on the
reliability of administrative databases in estimating such indicators.
Materials and Methods
Ethics
No identifiable human data were used for this study. The
dataset used in the study is not openly available. According to the
Italian law on data confidentiality (decree 196/2003), permission
to use individual-level data, albeit non-identifiable, must be
granted by the institutions which bear the responsibility of the
custody of the data. Permission to use data extracted from
administrative databases for the VALORE project was granted to
Agenzia regionale di Sanita` della Toscana by ULSS 16 Padova
(Veneto region), ASP 7 Ragusa (Sicily region), Assessorato
Politiche per la Salute Emilia Romagna (Emilia Romagna region),
Zona Territoriale Senigallia (Marche region), which are respon-
sible for the custody of the data of the corresponding populations.
Agenzia regionale di sanita` della Toscana (Tuscany region) is
enabled by a regional law (40/2005) to use Tuscan data for
research purposes. Approval for use of encrypted and aggregated
data from the HSD was also obtained from the Italian College of
General Practitioners.
Setting
Italy has a tax-based, universal coverage national health system
organised in three levels: national; regional (21 regions); and local
(on average 10 Local Health Authorities per region). Healthcare is
managed for every inhabitant by the Local Health Authority
where she has her regular address [19]. Coordination of primary
care within a Local Health Authority is performed at a smaller
geographical level called Health District [18]. Every Italian
inhabitant is entitled to choose a GP, although parents might
opt for a specialist paediatrician instead for their children, up to
the age of 15. Therefore, each inhabitant from the age of 16
onward is specifically associated with a GP. GPs are the
‘‘gatekeepers’’ of the system, meaning that only upon GP
prescription can specialist encounters be obtained free of charge.
Dispensing of drugs or administration of diagnostic procedures can
be obtained free of charge upon prescription of either a GP or a
specialist physician employed by the healthcare system [19].
The five regions which contributed data to the VALORE
validation study were: Veneto (A, Northern Italy), Emilia
Romagna (B, Northern Italy), Tuscany (C, Central Italy), Marche
(D, Central Italy) and Sicily (E, Southern Italy).
Study design
The VALORE project had selected several indicators to
measure compliance with standards of care for diabetes, IHD
and HF. In each region from the pool of regional GPs two
convenience samples of groups of GPs were extracted and
included in the validation study. In each regional pair, GPs of
one sample had indicators computed from administrative data-
bases, GPs of the other from their own clinical databases.
Measurements of indicators were compared within and between
regions.
The true values of an indicator across all the GPs in a region are
an unobservable distribution. The rationale of this study design is
based on the assumption that if measurements performed with two
different methods in two different samples of GPs provide similar
results, the likelihood that they both measure the true distribution
is higher than the likelihood that they systematically make the
same mistakes across different regions.
Data collection: sample of GPs with administrative-based
measures
The national Italian government has mandated since the early
Nineties collection of healthcare administrative data across the
whole country. The healthcare activities which are mandated to be
reported to the government have progressively expanded, from
inpatient care [20] to drug dispensings and diagnostic tests [21].
Moreover an inhabitant registry is maintained by each Local
Health Authority, where the GP chosen by the inhabitant is
recorded, as well as other information, such as gender, birth date,
date of entry in the territory of the Local Health Authority, date of
exit from the territory [21]. However, outpatient diagnoses are not
recorded in health administrative databases yet. Therefore cohorts
of patients with chronic diseases must be selected by means of
disease-specific longitudinal algorithms involving hospital dis-
charges diagnoses, drug and/or other healthcare services utiliza-
tion.
In each region, a convenience sample of Health Districts was
chosen. All the GPs serving in those Health Districts were
identified from the inhabitant registries of the corresponding Local
Health Authorities and included in the sample. The healthcare
administrative data of the whole population who chose a GP in
this sample was loaded in the VALORE database. Patients aged
16–95 with diabetes, IHD and/or HF at the index date 1/1/2009
were detected by means of ad hoc algorithms based on past
healthcare received. More details on this process are described
elsewhere [22]. Indicators were computed during a one-year
follow-up by linking the cohorts to the administrative databases of
drug dispensings and diagnostic tests.
GPs were excluded from the samples if they had less than 300
persons registered or less than 4 patients with the disease, as
indicators computed on small numbers were considered to be non
robust.
Italian Databases for Standards of Care in Chronic Diseases
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Data collection: sample of GPs with clinical-based
measures
The samples of GPs with clinical-based measures were drawn
from the Health Search CSD Longitudinal Patient Database
(HSD), a longitudinal observational database that is representative
of the general Italian population. HSD was established in 1998 by
the Italian College of General Practitioners and, at the time when
the study was conducted, it contained data from from more than
800 GPs throughout Italy, covering a total population of around
1.2 million patients [23]. The GPs participating in HSD all use the
same information software, in which they record demographic
information, visits and referrals, diagnoses, drug and diagnostic
tests prescriptions and clinical information of their patients. They
are accepted as participants in HSD if their records are arguably
complete, i.e. the prevalence of the principal diseases measured
from their records is comparable with the expected prevalence of
the general population. For this study, data from the 190 GPs
practicing in the five regions of the VALORE project were used.
The study population comprised patients aged 16-95 who had
been registered with the GP for at least two years and were alive
on 1st January 2009. Patients with diabetes, IHD and/or HF at
the index date 1/1/2009 were detected by means of algorithms
based on recorded diagnosis, which is described in detail elsewhere
[22]. Indicators were computed from the prescribed drugs or
diagnostic tests.
Indicators
The indicators that were included in the study are shown in
Table 1, and are classified as therapy indicators (for IHD and HF
only), laboratory diagnostic tests, and bio-imaging diagnostic tests
(HF only). All the indicators were based on clinical guidelines for
the management of the disease that recommended regular therapy
and yearly testing, respectively. The standard for a therapy
recommendation was considered to be compliant with when at
least two dispensings (in VALORE) or prescriptions (in HSD) were
recorded in 2009, at least 180 days the one from the other. The
standard for a diagnostic recommendation (laboratory or bioima-
ging) was considered to be achieved when at least one test was
performed (in VALORE) or prescribed (in HSD) during 2009.
Statistical analysis
In each sample the number of GPs, the number, age and gender
distribution of patients aged 16+, and the average number of
patients per GP were computed, both for the general population
and for the population with each of the diseases. Differences in the
variables within each regional pair of samples were tested either by
a two-tail difference in means or a Chi-square test.
For each GP indicators were computed as percentage of
patients who were compliant with the recommended standards of
care. The distribution of the indicators of each regional pair were
represented in a box-plot. To test whether each pair of
measurements was drawn from the same distribution, the non-
parametric Wilcoxon-Mann-Whitney two-sample statistic (also
known as Wilcoxon rank-sum statistic) was performed in each
region and for each indicator. In a sensitivity analysis, the test was
repeated for achievements of standards in patients aged 45–74
years.
Data management and data analysis were performed with Stata
10.1.
Results
Of the 1671 GPs serving in the Health Districts participating to
the VALORE study, 1501 (89.8%) had enough registered patients
and entered the study. Few GPs were discarded from the disease-
specific studies because they had less than four patients, the
maximum was the 7% of GPs in region A in the HF study. All the
190 GPs in the HSD sample entered the study.
The description of the study population is shown in Table 2.
Every HSD sample contained less GPs than the VALORE sample.
The GPs in the HSD sample had a bigger registered population on
average in all the five samples (range in HSD: 1238–1431, range in
VALORE: 925–1223). The average number of patients per GP
was higher in HSD GPs as well for diabetes (range in HSD 92.0–
107.5, range in VALORE: 55.9–81.6) and IHD (range in HSD:
50.8–78.6, range in VALORE: 40.0–61.9), but for HF the
numbers were similar in the two groups (range in HSD: 13.7–
22.2, range in VALORE: 12.8–20.0). Age distribution was
different within all pairs in all the populations, and the VALORE
samples were older except in region B. Women were slightly more
represented in the VALORE populations, except again in region B
and in region E. This difference in gender did not show up in
diabetic patients and was not consistent across regions in IHD and
HF patients.
Figure 1 shows the box-plots of the pairs of distributions of the
crude values of each indicator. A qualitative examination of the
box-plots detected that distributions are very similar within the
pairs. A notable exception are laboratory measurements in region
E and bio-imaging test in all the regions, and VALORE showed
lower values in all cases. The geographical trends, represented by
orderings of the median values of the distributions, were similar
between regions when measured in either data source, but less so
in the case of the bio-imaging test.
Table 3 shows the results of the Wilcoxon-Mann-Whitney tests.
Among therapy indicators the test found no differences in the
distributions, with the exception of the samples in region C and,
for HF only, region A, and the VALORE samples had higher
values. The test confirmed that the distributions for all the
laboratory diagnostic indicators of region E were different. Among
diabetes the test detected slightly different distributions in three
regions in either of the indicators, and in the IHD indicator region
C and B had different distributions. The test confirmed that the
only indicator of bio-imaging testing resulted in incoherent
Table 1. List of indicators.
Therapy ($2 dispensations per year,
distance .180 days)
Laboratory diagnostic test
($1 per year)
Imaging diagnostic test
($1 per year)
Diabetes Creatinine, Glycated emoglobin
IHD ACE inhibitors, Antithrombotics Total colesterol
HF ACE inhibitors, Beta-blockers Ecocardiogram
Indicators for the care of chronic diseases selected by the VALORE project and included in the validation study.
doi:10.1371/journal.pone.0095419.t001
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measurements in all but one region. Restricting the distributions to
age-specific indicators (45–74) improved the comparability of the
distributions of the therapy indicators of HF, and left unchanged
the comparability of the other indicators.
Discussion
Even though in Italy the data items to be collected in health
administrative databases are mandated by the central govern-
ment, and the resulting central databases are therefore
formally homogeneous, data collection takes place locally.
Italy is characterized by long-standing regional differences in
general and in healthcare in particular [24]. Therefore it is
possible that inaccurate local data collection processes hamper
data quality and completeness, and in particular quality of
personal identifiers that allow for record-linkage. Moreover,
outpatient diagnosis are not among the data items collected,
therefore identification of cohorts of patients with chronic
diseases must rely on algorithms linking inpatient diagnosis
with drug and other healthcare services utilization. Inhomo-
geneous quality of personal identifiers and completeness of
recordings might lead to inhomogeneous accuracy in defining
cohorts of patients and in identifying healthcare services that
they access. This in turn might result in non-comparable
measures of compliance with standards of care for chronic
diseases.
This study addressed this concern by comparing such measures
with measures obtained from a different data source, in five Italian
regions. The database which was chosen as a comparator collects
clinical data from GPs, and is therefore complementary to the
healthcare administrative data.
The results show that administrative databases provide reliable
estimates on regional level. Indeed, the four therapy indicators had
the same distribution within the pairs of regional samples in the
large majority of cases. The same was observed for the three
diagnostic indicators except in one region, where the distributions
were systematically different. The only bio-imaging indicator had
different distributions within pairs. Geographical trends between
regions were consistent across the two data sources. This provides
evidence that the two data sources both estimate the same
population distribution, thus supporting the use of indicators
computed on health administrative databases for comparisons
between regions.
It was not possible to obtain measurements from the two data
sources on the same samples of GPs. This was partly due to the
fact that the identity of the GPs belonging to the database HSD is
confidential. Moreover, data linkage at individual or even GP level
between different data sources had legal implications in terms of
privacy regulations and the procedures needed to obtain
permissions for such data collection [25] could not be managed
in the context of the VALORE Project.
Therefore, observed differences in the distributions might be
attributable to the composition of the following main effects: (a)
due to non-random selection of the two samples, the GPs in the
two samples were qualitatively different with actually different
performance; (b) due to the different selection process that was
conducted in the two type of data sources, the cohorts of patients
of the two samples were qualitatively different subpopulations of
the actual patients, which actually received different care; (c)
difference in measurement, and HSD was likely biased (d)
difference in measurement, and VALORE was likely biased. In
the following paragraphs we provide plausible explanations to
disentangle the effect (d), which is the object of this study, from (a),
(b) and (c). It is a limitation of this study (see Limitations
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subsection) that some of the hypotheses we generated could not be
tested. For cause (b), the main reference is the study by Gini et al,
which found evidence that diabetic patients without therapy are
less prevalent in the VALORE sample, and patients with heart
failure are younger in the GP sample [22].
For therapy indicators some differences are observed for HF in
regions A and C. This is most likely due to reason (c), that is,
patients included in the cohorts of HSD samples are different
than patients included in the cohorts of the VALORE samples:
indeed, age distribution of patients is different within the pairs,
with the older cohort in VALORE being more likely to be
assisted at home or in residential facilities, where GPs are likely to
not record their activity completely [22,23]. To test this
assumption, analysis was restricted to patients aged 45–74, and
indeed differences disappeared in region C in one indicator and
in region A in both.
For laboratory testing indicators, region E seem to underesti-
mate consistently the actual values of the indicators, across the
three diseases. This could amount to incomplete collection of
administrative data from laboratories, or to higher use of out-of
pocket services: indeed, the most recent National Health Survey
found that in region E (Sicily) attitude to use diagnostic services
that are non reimbursed by the Health System is higher than in
the other regions participating to our study [26]. In the other
regions differences do not show a consistent pattern, except
perhaps in region C, where however (a) rather than (d) could be
the cause, that is, GPs in the HSD sample and GPs in the
VALORE sample in region C actually have different quality of
care. Indeed, in region C therapy indicators differ slightly between
samples as well.
The bio-imaging indicator is probably underestimated by
healthcare administrative databases: this might be due to out-of-
pocket payment of this analysis, or to the fact that bio-imaging
occurring during hospital admissions was not recorded by
VALORE.
The overall similarity in measurements that was observed in
this study generates in turn two observations. First, the standards
of care in the sample of GPs participating to the HSD database
seem to be representative of the distribution of the whole
population of GPs. This was surprising, as GPs in HSD are
selected because of completeness in their recordings, and good
recording habits were expected to be associated with better
standards of care. The second observation is that specialist
physicians who assist chronic patients are likely to involve GPs in
regular prescription of therapies and diagnostic tests: indeed, if
GPs were unaware of such prescriptions in the share of patients
who are visited by a specialist, their clinical data would detect
lower standards.
Our study was performed in samples drawn from regions
belonging to three macro-areas of the country. Only a study
performed in all regions could rule out the possibility that
major issues show up in other areas, however the evidence we
observed points to the direction of greater confidence. On the
other hand, we do not claim that our results support reliability
of similar measurements for any chronic disease. Indeed, this is
determined by how reliable the algorithm for identifying the
case is, and it was shown that this depends specifically on the
disease, as frequency of hospital use, specificity of drug
indication and pattern of healthcare may vary [22].
In summary, the evidence we provide is promising enough to
support comparison of regions with respect to indicators of
compliance with standards of care for diabetes, IHD, and HF.
Moreover, it supports the reliability of empirical studies, as the
VALORE study [18], using such indicators to evaluate the impact
of organizational innovation in primary care.
Limitations
In this study indicators were computed on a population level for
a convenience samples of GPs instead of directly being compared
on a patient level for the same GPs. Similarity between samples
could be due to random combination of contrasting effects rather
than being attributable to the factors that we discussed. Although
this is unlikely to have happened consistently in five regions, an
individual-level validation study only could address this concern.
Italy, like several other countries, has a national legislation that
Figure 1. Box-plots of the distribution of indicators of quality
of care for diabetes (2 indicators), IHD (3 indicators) and HF (3
indicators) in 5 pairs of samples of GPs. Each pair contains the
distribution obtained from the VALORE data (dark gray) and the
distribution obtained from HSD data (light gray). For each indicator
the pair of samples are ordered according to the median value in
the VALORE sample.
doi:10.1371/journal.pone.0095419.g001
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permits exemption to the requirement for patient consent for
projects in the public’s interest [25], but this pathway was too
complex to be faced in the context of the VALORE project.
It was not possible to test some of the hypotheses we generated
to explain observed differences. A study involving more regions
and different points in time could provide counterfactuals to test
our hypotheses.
Conclusion
According to the evidence presented in this study, estimating
compliance with standards of care for diabetes, ischaemic heart
disease and heart failure from healthcare databases is likely to
produce reliable results, even though completeness of data on
diagnostic procedures should be assessed first. Performing studies
comparing regions using such indicators as outcomes is a
Table 3. P-values of the Wilcoxon-Mann-Whitney tests.
Disease Indicators Region Pooled 45–74
Diabetes Creatinine test A 0.357 *
B 0.587 0.701
C 0.840 0.957
D * *
E ** **
Glycated emoglobin test A 0.628 0.653
B ** *
C * *
D 0.441 0.441
E ** **
Ischaemic heart disease ACE inhibitors A 0.728 0.067
B 0.695 0.671
C ** **
D 0.116 0.065
E 0.504 0.877
Antithrombotics A 0.508 0.174
B 0.328 0.084
C 0.651 0.440
D 0.497 0.588
E 0.754 0.095
Total cholesterol test A 0.225 0.962
B ** **
C * **
D 0.279 0.720
E ** **
Heart failure ACE inhibitors A * 0.960
B 0.454 0.107
C * *
D 0.701 0.961
E 0.267 0.052
Beta-blockers A * 0.670
B 0.389 0.490
C ** 0.091
D 0.914 0.523
E 0.293 0.614
Ecocardiogram A 0.134 0.245
B * *
C 0.059 0.944
D ** **
E ** **
P-values of the Wilcoxon-Mann-Whitney tests. P-values smaller than 0.05 are represented by a single star, P-values smaller than 0.001 are represented by a double star.
doi:10.1371/journal.pone.0095419.t003
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promising development with the potential to improve quality
governance in the Italian healthcare system.
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